Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
7.33
-0.08 (-1.08%)
At close: Aug 1, 2025, 4:00 PM
7.47
+0.14 (1.91%)
After-hours: Aug 1, 2025, 6:16 PM EDT
Sage Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $873.33 million as of August 1, 2025. Its market cap has increased by 336.59% in one year.
Market Cap
873.33M
Enterprise Value
771.03M
1-Year Change
336.59%
Ranking
Category
Stock Price
$7.33
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $873.33M, an increase of 927.58%. That is a compound annual growth rate of 45.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 873.33M | 137.20% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | 44.48M | -33.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |